Filter
1413
Text search:
specimen
Featured
Recommendations
216
New Publications
438
Language
Document type
No document type
846
Guidelines
275
Studies & Reports
123
Manuals
70
Strategic & Response Plan
38
Fact sheets
31
Training Material
13
Situation Updates
10
Infographics
3
Online Courses
2
Videos
2
Countries / Regions
India
116
South Africa
56
Kenya
48
Nigeria
46
Liberia
43
Sierra Leone
39
Ethiopia
33
Ghana
28
Global
28
Tanzania
27
Zambia
25
Rwanda
25
Africa
25
Malawi
24
Uganda
21
Namibia
20
Nepal
19
Congo, Democratic Republic of
16
Philippines
16
Western and Central Europe
16
Bangladesh
15
Zimbabwe
14
West and Central Africa
13
Latin America and the Carribbean
13
Lesotho
12
East and Southern Africa
10
Indonesia
9
Eastern Europe
8
Guinea
7
Botswana
7
Myanmar / Burma
7
South–East Asia Region
7
Germany
6
Mozambique
6
South Sudan
5
Syria
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Asia
5
Burkina Faso
4
Senegal
4
Mali
4
Pakistan
4
Cambodia
4
Eswatini/ Swaziland
4
Angola
4
Russia
4
USA
3
Afghanistan
3
Palestine
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Cameroon
2
Togo
2
Haiti
2
Somalia
2
Iraq
2
Lebanon
2
Thailand
2
Gambia
2
Benin
2
Brazil
2
Burundi
2
Libya
2
Yemen
2
Middle East and North Africa
2
Southern Africa
2
Tajikistan
2
Qatar
2
Vietnam
2
France
2
Spain
2
Jordan
1
Turkey
1
Egypt
1
Chad
1
China
1
Mauritania
1
Sudan
1
Central African Republic
1
Argentina
1
Peru
1
Ukraine
1
Madagascar
1
Sri Lanka
1
Paraguay
1
Djibouti
1
Timor Leste/ East Timor
1
Romania
1
Iran
1
Uzbekistan
1
Georgia
1
Gabon
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
619
Clinical Guidelines
181
Pharmacy & Technologies
68
Public Health
47
Key Resources
27
Women & Child Health
23
Capacity Building
18
Toolboxes
TB
180
COVID-19
153
Rapid Response
123
HIV
113
Ebola
80
AMR
69
NTDs
47
Zika
21
Caregiver
19
Pharmacy
18
Cholera
17
Polio
17
Mental Health
11
Natural Hazards
10
Planetary Health
9
Refugee
7
Conflict
5
Specific Hazards
5
NCDs
4
Health Financing Toolbox
3
Disability
1
Global Health Education
1
National Essential Diagnostic List
recommended
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma
...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
orientaciones provisionales, 8 de noviembre de 2020
This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e
...
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,
...
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del
...